ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in use- Beconase Hayfever Nasal Spray 180 Dose (P)

Omega Pharma Ltd has identified that there is text missing in Section 2 of the Patient Information Leaflet (PIL) in packs of Beconase Hayfever Nasal Spray (P).

 

MHRA drug alert date: 26th April 2023

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-omega-pharma-ltd-beconase-hayfever-nasal-spray-el-23-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bcaed696-a02b-4ec1-bbed-8bd2b462dab8&utm_content=immediately

 

Pip code

Product Description

Affected Batches

2149839

 

BECONASE ALLERGY 180 SPRAYS

SEE LINK ABOVE

This is a caution in use only we are not accepting stock returns.

 

Further Information

For medical information, stock control queries and Patient Information Leaflet (PIL) requests, please contact: UKLOcustomerservice@perrigo.com